PackTalk is a blog for the Healthcare Packaging Industry

FDA Pilots Programs to Enhance Traceability


Published on July 30, 2020

What is happening with FDA Title II Drug Supply Chain Security Act (DSCSA)?

In October 2014, the FDA issued draft guidance in response to Title II (a/k/a the DSCSA) of the Drug Quality and Security Act (DQSA) of 2013. The requirements and compliance deadlines of the Act include Section 5851, establishing pharmaceutical traceability, wholesale distributor and third-party logistics standards and regulations.

The FDA has continued to refine portions of the DCSCA draft guidance that has included publication of final guidance for certain portions. Specific to the traceability and supply chain processes and Section 585, the FDA announced the undertaking of a pilot project in 2017, with a call for comments and pilot participants from the pharmaceutical industry. The purpose of the pilot program is to test new technology in the pharmaceutical manufacturing setting, seeking best practice processes for traceability systems. The Act is currently set for full adoption by 2023.

As the industry watches the progress of this significant initiative, this article offers a summary of the activities and outcomes that have taken place so far. The most recent action published by the FDA relating to the supply chain pilot projects was the 2019 reopening of industry comment period and request for information regarding the pilot projects, extending the comment period to June 28, 2022. We are watching eagerly for anticipated pilot program reporting in the months ahead.

Read More

 

You might also like Full FDA DSCSA timeline

Source: (Uniform National Policy) of the Federal Food, Drug, and Cosmetic Act (FD&C Act),


Comments (0)

Related Articles

MedTech Conference Hot Topics

November 14, 2020

AdvaMed’s conference takes on medtech’s need to actively increase diversity and inclusion and fight racism, now.

If there is one thing we’ve learned in 2020, it is that our industry, along with others, must take a stand against racial injustice. AdvaMed’s...

Learn More

MD&DI Interviews FDA Commissioner

November 14, 2020

How the FDA continues to generate the science and data of a pandemic, keep the public health on active duty, and serve innovation, in the year that upended the world.

On April 1st, 2020, we published a blog post on the Herculean effort taking place between...

Learn More

How to Assess a Failure Observed Post-Transit

November 14, 2020

Transit failures happen. In fact, one in three transit or distribution studies that come through our lab fail. Sometimes intentionally to test the limits of a package, other times it can be unexpected and bring a project to a halt. When we know what caused...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.